Fibronostics is a startup that aims to improve the treatment, screening, follow-up and prognosis with non-invasive algorithm based diagnostics. The company, founded in October 2015, is backed by Sprim Ventures. The vast startup portfolio of Sprim Ventures is an opportunity to be able to work on a wide range of projects and challenges.
Furthermore, this is an unique opportunity to work directly with the Sprim CEO, the board and healthcare professionals and gain deep insights on the healthcare business while applying your technical skills in machine learning, deep learning and software engineer.
Join and help us disrupt the Healthcare industry.